Publication

Mastiha (Pistacia Lentiscus) improves gut microbiota diversity, hepatic steatosis and disease activity in a biopsy-confirmed mouse model of advanced non-alcoholic steatohepatitis and fibrosis

Molecular Nutrition & Food Research 63(24):e1900927, 2019

Kannt A, Papada E, Kammermeier C, D’Auria G, Jiménez-Hernández N, Stephan M, Schwahn U, Madsen AN, Ostergaard MV, Dedoussis G; MAST4HEALTH consortium

Share this page

Resource Library

Related resources

The selective peroxisome proliferator‐activated receptor gamma modulator CHS‐131 improves liver histopathology and metabolism in a mouse model of obesity and nonalcoholic steatohepatitis

Preclinical efficacy and clinical translatability of elafibranor in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Metabolic, biochemical and histological effects of semaglutide in a CDAA-HFD-induced non-obese and biopsy-confirmed rat model of NASH with progressive fibrosis and tumor development

Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650